Last year, a ten-month-old baby in the US was the first person in the world to have their rare genetic disease effectively ...

Researchers developed a chemogenetic system combining caffeine, nanobodies, and CRISPR to control gene editing. The approach ...

Researchers developed a CRISPR and single-molecule microarray test that quantifies Candida auris and detects antifungal ...

Australian scientists have used AI to design molecules that make gene editing technology safer, potentially revolutionising ...

Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...

Intellia is instituting new safeguards following the death of a study participant that led regulators to pause two trials in ...

One of the most inherent risks is the risk of damaging healthy genes. This rather brutal issue is step one of risk management. It also means large sequences of amino acids that must be checked, ...

Gene-editing techniques such as CRISPR have enabled new treatments for previously incurable diseases. Researchers at the ...

Caffeine could act as an on-off switch for gene and cell therapies, giving doctors more precise control over powerful ...

After a patient safety signal and then death, the FDA in October 2025 placed holds on two of the company’s CRISPR programs ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $54.65, marking a -1.57% move from the previous day. This move lagged the S&P 500's daily gain of 0.5%. On the other hand, the ...